Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 21, 2025 01:19 ET | Source: Herantis Pharma plc

Herantis Pharma releases 1H 2025 report today

Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025...
August 14, 2025 09:02 ET | Source: Herantis Pharma plc

Last patient visit completed on schedule in Phase 1b clinical trial of HER-096 for Parkinson’s disease

Patient visits are now complete in the final cohort of Phase 1b trial, consisting of Parkinson’s disease patients receiving 300 mg doses of HER-096 or placebo twice weekly over a four-week...